Search Results 891-900 of 18367 for Hepatitis b

1. A Safety, Methodological and Exploratory Biomarkers Study to Slow Disease Progression - Mayo Clinic

   History of +VE test result indicating active hepatitis C or B (defined as both hepatitis B surface antigen and hepatitis core antibody +VE). Uncontrolled ...

2. Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease - Mayo Clinic

   HBV immune participants (ie, being hepatitis B surface antigen [HBsAg] negative and hepatitis B antibody positive) may, however, be included. History of any ...

3. Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis - Mayo Clinic

   - STEP 1: Participants must not be seropositive for hepatitis B (defined by a positive test for hepatitis B surface antigen [HBsAg]). Subjects with resolved ...

4. Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence - Mayo Clinic

   ... B/C/D, or Stage IV cutaneous melanoma who are at high risk for recurrence ... Any positive test result for hepatitis B virus or hepatitis C virus ...

5. Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production - Mayo Clinic

   C virus or hepatitis B virus including: Chronic or active hepatitis B as diagnosed by serologic tests. In equivocal cases, hepatitis B or C polymerase chain ...

6. Radiation Therapy with Durvalumab or Cetuximab to Treat Patients with Locoregionally Advanced Head and Neck Cancer who Cannot Take Cisplatin - Mayo Clinic

   ... hepatitis B (known positive hepatitis B virus [HBV] surface antigen [HBsAg] result), hepatitis C; patients with a past or resolved HBV infection (defined as ...

7. A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma - Mayo Clinic

   Known to be seropositive for hepatitis B (defined by a positive test for hepatitis B surface antigen [HBsAg]). Subjects with resolved infection (e.g. ...

8. A Study of DFRF4539A in Patients with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Positive for hepatitis B, hepatitis C or HIV infection; Pregnant or lactating ... B. Contact information: Cancer Center Clinical Trials Referral Office.

9. Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity- AIM 1 - Mayo Clinic

   - Hepatitis B or C positive - Heavy alcohol use - Active smoking history - Active cancer history - History of asthma - History of COPD - Taking Plavix or ...

10. A Study of Entrectinib (RXDX-101) for the Treatment of Patients with Solid Tumors that have NTRK1/2/3, ROS1, or ALK Gene Rearrangements - Mayo Clinic

    ... B/C, ROS1, or ALK kinase domain, respectively, without a concomitant second ... hepatitis B virus (HBV), and hepatitis C virus (HCV) infections, as ...